Reports
Sale
Global Guillain-Barre Syndrome Treatment Market Share, Size, Trends: By Treatment: Intravenous Immunoglobulin, Plasma Exchange, Others; By Route of Administration: Oral, Parental; By Distribution Channels:Hospital Pharmacies, Retail Pharmacies, Others; Regional Analysis;Competitive Landscape: Industry Events and Developments; 2023-2028
Global Guillain-Barre Syndrome Treatment Market Outlook
The global Guillain-Barre syndrome treatment market is estimated to grow in the forecast period of 2023-2028 at a CAGR of 5.4%.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
North America to Hold a Substantial Share in the Market Growth of Guillain-Barre Syndrome Treatments
North America is projected to register a substantial share in the Guillain-Barre syndrome treatment market over the forecast period owing to the high number of cases in the region. The presence of a well-established healthcare infrastructure is expected to drive the market growth in North America. The growth would be supplemented by with the growing geriatric population as they are more sensitive to catching infections because of their low immunity that further requiring effective therapy.
Going further, the growing per capita healthcare expenditure along with a huge patient population and changing lifestyles is likely to drive the market. The existence of developed economies like Canada and the United States along with high awareness among end-users and high cost of therapeutic products are expected to fuel regional growth.
Market Segmentation
Guillain-Barre syndrome is a rare disorder in which the immune system of the body attacks the nerves. Weakness and tingling in the feet and hands are generally the first symptoms. Such sensations can spread quickly, sooner or later paralysing the whole body. In its most severe form, the syndrome is called a medical emergency. Most people with this disorder must be hospitalised to obtain treatment.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
By treatment, the Guillain-Barre syndrome treatment market is divided into:
- Intravenous Immunoglobulin
- Plasma Exchange
- Others
Based on the route of administration, the treatment market is bifurcated into:
- Oral
- Parental
On the basis of distribution channel, the market is categorised into:
- Hospital Pharmacies
- Retail Pharmacies
- Others
The EMR report looks into the regional markets of Guillain-Barre syndrome treatment like Latin America, North America, Europe, Asia Pacific, and the Middle East and Africa.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Growing Adoption of Intravenous Immunoglobulin Treatment to Fuel the Market Growth of Guillain-Barre Syndrome Treatment
On the basis of treatments, the intravenous immunoglobulin segment is expected to fuel the market growth over the coming years. This is on account of the growing adoption of treatment by off-label usage of intravenous immunoglobulins owing to the increasing prevalence of dermatomyositis, multifocal motor neuropathy, relapsing-remitting multiple sclerosis, polymyositis, and stiff person syndrome.
The accessibility of an extensive range of intravenous immunoglobulin products like Gamunex, Privigen, and Gammagard is expected to drive the growth of the market. Intravenous immunoglobulin is utilised to lower the effects of certain inflammatory conditions that impact the immune system, also known as autoimmune diseases. Moreover, technological advancements in diagnosis and treatment are expected to bolster the market growth across the region during the forecast period.
Key Players in the Global Market for Guillain-Barre Syndrome Treatment
The report presents a detailed analysis of the following key players in the global market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:
- CSL Behring
- Kedrion S.p.A
- Cellenkos Inc.
- Takeda Pharmaceutical Company Limited.
- Hansa Biopharma AB
- Others
The comprehensive report looks into the macro and micro aspects of the market. The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
|---|---|
| Base Year | 2022 |
| Historical Period | 2018-2022 |
| Forecast Period | 2023-2028 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Treatment |
|
| Breakup by Route of Administration |
|
| Breakup by Distribution Channels |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Market Snapshot
6.1 Global
6.2 Region
7 Opportunities and Challenges in the Market
8 Global Guillain-Barre Syndrome Treatment Market Analysis
8.1 Key Industry Highlights
8.2 Global Guillain-Barre Syndrome Treatment Historical Market (2018-2022)
8.3 Global Guillain-Barre Syndrome Treatment Market Forecast (2023-2028)
8.4 Global Guillain-Barre Syndrome Treatment Market by Treatment
8.4.1 Intravenous Immunoglobulin
8.4.1.1 Historical Trend (2018-2022)
8.4.1.2 Forecast Trend (2023-2028)
8.4.2 Plasma Exchange
8.4.2.1 Historical Trend (2018-2022)
8.4.2.2 Forecast Trend (2023-2028)
8.4.3 Others
8.5 Global Guillain-Barre Syndrome Treatment Market by Route of Administration
8.5.1 Oral
8.5.1.1 Historical Trend (2018-2022)
8.5.1.2 Forecast Trend (2023-2028)
8.5.2 Parental
8.5.2.1 Historical Trend (2018-2022)
8.5.2.2 Forecast Trend (2023-2028)
8.6 Global Guillain-Barre Syndrome Treatment Market by Distribution Channels
8.6.1 Hospital Pharmacies
8.6.1.1 Historical Trend (2018-2022)
8.6.1.2 Forecast Trend (2023-2028)
8.6.2 Retail Pharmacies
8.6.2.1 Historical Trend (2018-2022)
8.6.2.2 Forecast Trend (2023-2028)
8.6.3 Others
8.7 Global Guillain-Barre Syndrome Treatment Market by Region
8.7.1 North America
8.7.1.1 Historical Trend (2018-2022)
8.7.1.2 Forecast Trend (2023-2028)
8.7.2 Europe
8.7.2.1 Historical Trend (2018-2022)
8.7.2.2 Forecast Trend (2023-2028)
8.7.3 Asia Pacific
8.7.3.1 Historical Trend (2018-2022)
8.7.3.2 Forecast Trend (2023-2028)
8.7.4 Latin America
8.7.4.1 Historical Trend (2018-2022)
8.7.4.2 Forecast Trend (2023-2028)
8.7.5 Middle East and Africa
8.7.5.1 Historical Trend (2018-2022)
8.7.5.2 Forecast Trend (2023-2028)
9 North America Guillain-Barre Syndrome Treatment Market Analysis
9.1 United States of America
9.1.1 Historical Trend (2018-2022)
9.1.2 Forecast Trend (2023-2028)
9.2 Canada
9.2.1 Historical Trend (2018-2022)
9.2.2 Forecast Trend (2023-2028)
10 Europe Guillain-Barre Syndrome Treatment Market Analysis
10.1 United Kingdom
10.1.1 Historical Trend (2018-2022)
10.1.2 Forecast Trend (2023-2028)
10.2 Germany
10.2.1 Historical Trend (2018-2022)
10.2.2 Forecast Trend (2023-2028)
10.3 France
10.3.1 Historical Trend (2018-2022)
10.3.2 Forecast Trend (2023-2028)
10.4 Italy
10.4.1 Historical Trend (2018-2022)
10.4.2 Forecast Trend (2023-2028)
10.5 Others
11 Asia Pacific Guillain-Barre Syndrome Treatment Market Analysis
11.1 China
11.1.1 Historical Trend (2018-2022)
11.1.2 Forecast Trend (2023-2028)
11.2 Japan
11.2.1 Historical Trend (2018-2022)
11.2.2 Forecast Trend (2023-2028)
11.3 India
11.3.1 Historical Trend (2018-2022)
11.3.2 Forecast Trend (2023-2028)
11.4 ASEAN
11.4.1 Historical Trend (2018-2022)
11.4.2 Forecast Trend (2023-2028)
11.5 Australia
11.5.1 Historical Trend (2018-2022)
11.5.2 Forecast Trend (2023-2028)
11.6 Others
12 Latin America Guillain-Barre Syndrome Treatment Market Analysis
12.1 Brazil
12.1.1 Historical Trend (2018-2022)
12.1.2 Forecast Trend (2023-2028)
12.2 Argentina
12.2.1 Historical Trend (2018-2022)
12.2.2 Forecast Trend (2023-2028)
12.3 Mexico
12.3.1 Historical Trend (2018-2022)
12.3.2 Forecast Trend (2023-2028)
12.4 Others
13 Middle East and Africa Guillain-Barre Syndrome Treatment Market Analysis
13.1 Saudi Arabia
13.1.1 Historical Trend (2018-2022)
13.1.2 Forecast Trend (2023-2028)
13.2 United Arab Emirates
13.2.1 Historical Trend (2018-2022)
13.2.2 Forecast Trend (2023-2028)
13.3 Nigeria
13.3.1 Historical Trend (2018-2022)
13.3.2 Forecast Trend (2023-2028)
13.4 South Africa
13.4.1 Historical Trend (2018-2022)
13.4.2 Forecast Trend (2023-2028)
13.5 Others
14 Market Dynamics
14.1 SWOT Analysis
14.1.1 Strengths
14.1.2 Weaknesses
14.1.3 Opportunities
14.1.4 Threats
14.2 Porter’s Five Forces Analysis
14.2.1 Supplier’s Power
14.2.2 Buyer’s Power
14.2.3 Threat of New Entrants
14.2.4 Degree of Rivalry
14.2.5 Threat of Substitutes
14.3 Key Indicators for Demand
14.4 Key Indicators for Price
15 Competitive Landscape
15.1 Market Structure
15.2 Company Profiles
15.2.1 CSL Behring
15.2.1.1 Company Overview
15.2.1.2 Product Portfolio
15.2.1.3 Demographic Reach and Achievements
15.2.1.4 Certifications
15.2.2 Kedrion S.p.A
15.2.2.1 Company Overview
15.2.2.2 Product Portfolio
15.2.2.3 Demographic Reach and Achievements
15.2.2.4 Certifications
15.2.3 Cellenkos Inc.
15.2.3.1 Company Overview
15.2.3.2 Product Portfolio
15.2.3.3 Demographic Reach and Achievements
15.2.3.4 Certifications
15.2.4 Takeda Pharmaceutical Company Limited.
15.2.4.1 Company Overview
15.2.4.2 Product Portfolio
15.2.4.3 Demographic Reach and Achievements
15.2.4.4 Certifications
15.2.5 Hansa Biopharma AB
15.2.5.1 Company Overview
15.2.5.2 Product Portfolio
15.2.5.3 Demographic Reach and Achievements
15.2.5.4 Certifications
15.2.6 Others
16 Key Trends and Developments in the Market
List of Key Figures and Tables
1. Global Guillain-Barre Syndrome Treatment Market: Key Industry Highlights, 2018 and 2028
2. Global Guillain-Barre Syndrome Treatment Historical Market: Breakup by Treatment (USD Million), 2018-2022
3. Global Guillain-Barre Syndrome Treatment Market Forecast: Breakup by Treatment (USD Million), 2023-2028
4. Global Guillain-Barre Syndrome Treatment Historical Market: Breakup by Route of Administration (USD Million), 2018-2022
5. Global Guillain-Barre Syndrome Treatment Market Forecast: Breakup by Route of Administration (USD Million), 2023-2028
6. Global Guillain-Barre Syndrome Treatment Historical Market: Breakup by Distribution Channels (USD Million), 2018-2022
7. Global Guillain-Barre Syndrome Treatment Market Forecast: Breakup by Distribution Channels (USD Million), 2023-2028
8. Global Guillain-Barre Syndrome Treatment Historical Market: Breakup by Region (USD Million), 2018-2022
9. Global Guillain-Barre Syndrome Treatment Market Forecast: Breakup by Region (USD Million), 2023-2028
10. North America Guillain-Barre Syndrome Treatment Historical Market: Breakup by Country (USD Million), 2018-2022
11. North America Guillain-Barre Syndrome Treatment Market Forecast: Breakup by Country (USD Million), 2023-2028
12. Europe Guillain-Barre Syndrome Treatment Historical Market: Breakup by Country (USD Million), 2018-2022
13. Europe Guillain-Barre Syndrome Treatment Market Forecast: Breakup by Country (USD Million), 2023-2028
14. Asia Pacific Guillain-Barre Syndrome Treatment Historical Market: Breakup by Country (USD Million), 2018-2022
15. Asia Pacific Guillain-Barre Syndrome Treatment Market Forecast: Breakup by Country (USD Million), 2023-2028
16. Latin America Guillain-Barre Syndrome Treatment Historical Market: Breakup by Country (USD Million), 2018-2022
17. Latin America Guillain-Barre Syndrome Treatment Market Forecast: Breakup by Country (USD Million), 2023-2028
18. Middle East and Africa Guillain-Barre Syndrome Treatment Historical Market: Breakup by Country (USD Million), 2018-2022
19. Middle East and Africa Guillain-Barre Syndrome Treatment Market Forecast: Breakup by Country (USD Million), 2023-2028
20. Global Guillain-Barre Syndrome Treatment Market Structure.
Key Questions Answered in the Report
The global market is assessed to grow at a CAGR of 5.4% between 2023 and 2028.
The major market drivers are the growing prevalence of the syndrome and the surging healthcare industry.
The key market trends include huge investments in research and development and the rising usage of IVIG in off-label indications.
The major regions in the market are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
The various treatments in the market include intravenous immunoglobulin, and plasma exchange, among others.
The major routes of administration in the market include oral and parental.
The various distribution channels in the market include hospital pharmacies and retail pharmacies, among others.
The major players in the market are CSL Behring, Kedrion S.p.A, Cellenkos Inc., Takeda Pharmaceutical Company Limited., and Hansa Biopharma AB, among others.
Purchase Options
Call us on
Purchase Full Report
Mini Report
$ 2199
$1799
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next UpdateSingle User License
$3199$2999-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next Update
Five User License
$4199$3999-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$5199$4999-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Contact AnalystAny Question? Speak With An Analyst
Request SampleView A Sample
Request CustomisationDid You Miss Anything, Ask Now
Why Expert Market Research?Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
Similar Reports
NEWSLETTER